Published in World Neurosurg on October 11, 2011
The real meaning of the world Federation of neurological societies 2013 meeting in seoul. J Korean Neurosurg Soc (2013) 1.08
Certification in neurosurgery--worldwide perspective. World Neurosurg (2011) 0.75
Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature (2002) 15.36
Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. Cancer Res (2003) 8.06
The prevalence of pituitary adenomas: a systematic review. Cancer (2004) 2.98
Somatic activation of AKT3 causes hemispheric developmental brain malformations. Neuron (2012) 2.84
Epidemiology of intracranial meningioma. Neurosurgery (2005) 2.60
A 24-year-old woman with intractable seizures: review of surgery for epilepsy. JAMA (2008) 2.55
Spinal cord ependymoma: radical surgical resection and outcome. Neurosurgery (2002) 2.26
The prognostic significance of phosphatidylinositol 3-kinase pathway activation in human gliomas. J Clin Oncol (2004) 2.24
Autophagic survival in resistance to histone deacetylase inhibitors: novel strategies to treat malignant peripheral nerve sheath tumors. Cancer Res (2010) 2.11
Clinical, pathological, and molecular variables predictive of malignant peripheral nerve sheath tumor outcome. Ann Surg (2009) 2.04
Survival rates in patients with low-grade glioma after intraoperative magnetic resonance image guidance. Cancer (2005) 1.97
Multiple craniotomies in the management of multifocal and multicentric glioblastoma. Clinical article. J Neurosurg (2010) 1.85
Intravascular delivery of neural stem cell lines to target intracranial and extracranial tumors of neural and non-neural origin. Hum Gene Ther (2003) 1.65
IDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resection. Neuro Oncol (2013) 1.63
History of allergies and autoimmune diseases and risk of brain tumors in adults. Int J Cancer (2002) 1.62
Targeting of melanoma brain metastases using engineered neural stem/progenitor cells. Neuro Oncol (2006) 1.57
A genome-wide screen reveals functional gene clusters in the cancer genome and identifies EphA2 as a mitogen in glioblastoma. Cancer Res (2006) 1.54
Phase II study of protracted daily temozolomide for low-grade gliomas in adults. Clin Cancer Res (2009) 1.52
Textiloma (gossypiboma) mimicking recurrent intracranial tumor. Arch Pathol Lab Med (2004) 1.51
DNA repair gene polymorphisms and risk of adult meningioma, glioma, and acoustic neuroma. Neuro Oncol (2009) 1.51
Reproductive and hormonal factors and risk of brain tumors in adult females. Int J Cancer (2005) 1.50
Survival rates and patterns of care for patients diagnosed with supratentorial low-grade gliomas: data from the SEER program, 1973-2001. Cancer (2006) 1.49
Human neural stem cells target experimental intracranial medulloblastoma and deliver a therapeutic gene leading to tumor regression. Clin Cancer Res (2006) 1.44
Supratentorial low-grade glioma resectability: statistical predictive analysis based on anatomic MR features and tumor characteristics. Radiology (2006) 1.42
Non-rigid alignment of pre-operative MRI, fMRI, and DT-MRI with intra-operative MRI for enhanced visualization and navigation in image-guided neurosurgery. Neuroimage (2006) 1.41
In vitro and in vivo activity of the nuclear factor-kappaB inhibitor sulfasalazine in human glioblastomas. Clin Cancer Res (2004) 1.40
Human bone marrow-derived mesenchymal stromal cells expressing S-TRAIL as a cellular delivery vehicle for human glioma therapy. Stem Cells (2009) 1.40
Intracranial meningeal hemangiopericytoma: the role of radiotherapy: report of 29 cases and review of the literature. Cancer (2004) 1.39
Immediate titanium mesh cranioplasty for treatment of postcraniotomy infections. World Neurosurg (2011) 1.39
Neurosurgery certification in member societies of the WFNS: Europe. World Neurosurg (2011) 1.39
Targeting rat brainstem glioma using human neural stem cells and human mesenchymal stem cells. Clin Cancer Res (2009) 1.38
Capturing intraoperative deformations: research experience at Brigham and Women's Hospital. Med Image Anal (2004) 1.35
The mitosis-specific antibody anti-phosphohistone-H3 (PHH3) facilitates rapid reliable grading of meningiomas according to WHO 2000 criteria. Am J Surg Pathol (2004) 1.33
Dual targeting of AKT and mammalian target of rapamycin: a potential therapeutic approach for malignant peripheral nerve sheath tumor. Mol Cancer Ther (2009) 1.33
Metastatic disease from spinal chordoma: a 10-year experience. J Neurosurg Spine (2006) 1.33
Genetic polymorphisms in GSTM1, -P1, -T1, and CYP2E1 and the risk of adult brain tumors. Cancer Epidemiol Biomarkers Prev (2003) 1.28
SNAI2/Slug promotes growth and invasion in human gliomas. BMC Cancer (2010) 1.26
Cell-specific alterations of glutamate receptor expression in tuberous sclerosis complex cortical tubers. Ann Neurol (2008) 1.26
Lead, genetic susceptibility, and risk of adult brain tumors. Cancer Epidemiol Biomarkers Prev (2006) 1.23
Exogenous hormone use and meningioma risk: what do we tell our patients? Cancer (2007) 1.20
Aberrant splicing of cyclin-dependent kinase-associated protein phosphatase KAP increases proliferation and migration in glioblastoma. Cancer Res (2007) 1.17
Polymorphisms in apoptosis and cell cycle control genes and risk of brain tumors in adults. Cancer Epidemiol Biomarkers Prev (2007) 1.17
Awake craniotomy for brain tumors near eloquent cortex: correlation of intraoperative cortical mapping with neurological outcomes in 309 consecutive patients. Neurosurgery (2009) 1.16
Continuous intracranial administration of suberoylanilide hydroxamic acid (SAHA) inhibits tumor growth in an orthotopic glioma model. J Neurooncol (2007) 1.15
Image-guided neurosurgery at Brigham and Women's Hospital. IEEE Eng Med Biol Mag (2006) 1.14
Oxidative response gene polymorphisms and risk of adult brain tumors. Neuro Oncol (2008) 1.13
Polypyrimidine tract binding protein and Notch1 are independently re-expressed in glioma. Mod Pathol (2006) 1.09
PEX-producing human neural stem cells inhibit tumor growth in a mouse glioma model. Clin Cancer Res (2005) 1.08
High-resolution magic angle spinning magnetic resonance spectroscopy detects glycine as a biomarker in brain tumors. Int J Oncol (2010) 1.07
Neural stem cell biology may be well suited for improving brain tumor therapies. Cancer J (2003) 1.05
Matrix solution fixation: histology-compatible tissue preparation for MALDI mass spectrometry imaging. Anal Chem (2007) 1.05
Genomic profiling reveals alternative genetic pathways of meningioma malignant progression dependent on the underlying NF2 status. Clin Cancer Res (2010) 1.04
Vascular endothelial growth factor-stimulated cerebral microvascular endothelial cells mediate the recruitment of neural stem cells to the neurovascular niche. Brain Res (2009) 1.03
Neurosurgery certification in member societies of the World Federation of Neurosurgical Societies: Asia. World Neurosurg (2011) 1.03
Techniques and complications of external lumbar drainage for normal pressure hydrocephalus. Neurosurgery (2008) 1.02
Specific genes expressed in association with progesterone receptors in meningioma. Cancer Res (2008) 1.02
Positive and negative prognostic variables for patients undergoing spine surgery for metastatic breast disease. Eur Spine J (2007) 1.00
The Harvard Neurosurgical Service at the Children's Hospital Boston and Brigham & Women's Hospital, 1912-2007. Neurosurgery (2008) 1.00
Surgical management of unknown primary tumors metastatic to the spine. J Neurosurg Spine (2011) 1.00
Solid-state NMR adiabatic TOBSY sequences provide enhanced sensitivity for multidimensional high-resolution magic-angle-spinning 1H MR spectroscopy. J Magn Reson (2008) 0.99
intraoperative neuronavigation using diffusion tensor MR tractography for the resection of a deep tumor adjacent to the corticospinal tract. Stereotact Funct Neurosurg (2006) 0.99
Surgical management of primary and metastatic sarcoma of the mobile spine. J Neurosurg Spine (2008) 0.99
Altered inhibition in tuberous sclerosis and type IIb cortical dysplasia. Ann Neurol (2012) 0.98
Cancer in first-degree relatives and risk of glioma in adults. Cancer Epidemiol Biomarkers Prev (2003) 0.97
Sociodemographic indicators and risk of brain tumours. Int J Epidemiol (2003) 0.97
A recurrent craniopharyngioma illustrates the potential usefulness of urinary matrix metalloproteinases as noninvasive biomarkers: case report. Neurosurgery (2007) 0.97
Combination of high-resolution magic angle spinning proton magnetic resonance spectroscopy and microscale genomics to type brain tumor biopsies. Int J Mol Med (2007) 0.97
Surgical treatment strategies and outcome in patients with breast cancer metastatic to the spine: a review of 87 patients. Eur Spine J (2007) 0.96
Reduced allergy and immunoglobulin E among adults with intracranial meningioma compared to controls. Int J Cancer (2011) 0.96
Variation in genes relevant to aromatic hydrocarbon metabolism and the risk of adult brain tumors. Neuro Oncol (2006) 0.93
Spontaneous involution of Rathke cleft cysts: is it rare or just underreported? J Neurosurg (2010) 0.91
Case-control study of stereotactic radiosurgery for recurrent glioblastoma multiforme. J Neurosurg (2005) 0.91
Origins of intraoperative MRI. Neurosurg Clin N Am (2009) 0.91
Imaging of meningioma progression by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Anal Chem (2010) 0.91
A pilot safety study of lenalidomide and radiotherapy for patients with newly diagnosed glioblastoma multiforme. Int J Radiat Oncol Biol Phys (2008) 0.90
Occupation and risk of meningioma and acoustic neuroma in the United States. Am J Ind Med (2004) 0.90
The development of ring-shaped contrast enhancement in a case of cerebellar dysembryoplastic neuroepithelial tumor: case report. Neurosurgery (2008) 0.90
Alternative splicing of CHEK2 and codeletion with NF2 promote chromosomal instability in meningioma. Neoplasia (2012) 0.89
The association of breast cancer and meningioma in men and women. Neurosurgery (2009) 0.88
Subarachnoid-pleural fistula after resection of thoracic tumors. J Neurosurg (2004) 0.88
In vivo fate and therapeutic efficacy of PF-4/CTF microspheres in an orthotopic human glioblastoma model. FASEB J (2007) 0.88
Natural history of meningioma development in mice reveals: a synergy of Nf2 and p16(Ink4a) mutations. Brain Pathol (2007) 0.88
Treatment of patients with advanced neurofibromatosis type 2 with novel molecularly targeted therapies: from bench to bedside. J Clin Oncol (2011) 0.87
The value of ¹⁸F-FDG PET/CT in the management of malignant peripheral nerve sheath tumors. Eur J Nucl Med Mol Imaging (2014) 0.87
Genetic variation in insulin-like growth factors and brain tumor risk. Neuro Oncol (2008) 0.87
Combining curcumin (diferuloylmethane) and heat shock protein inhibition for neurofibromatosis 2 treatment: analysis of response and resistance pathways. Mol Cancer Ther (2011) 0.86
Local delivery of poly lactic-co-glycolic acid microspheres containing imatinib mesylate inhibits intracranial xenograft glioma growth. Clin Cancer Res (2009) 0.86
Subcortical injury is an independent predictor of worsening neurological deficits following awake craniotomy procedures. Neurosurgery (2013) 0.86
Induction of apoptosis in primary meningioma cultures by fenretinide. Cancer Res (2005) 0.86
Cyclic sciatica from extrapelvic endometriosis affecting the sciatic nerve. J Neurosurg Spine (2010) 0.86
Factors affecting survival in 267 consecutive patients undergoing surgery for spinal metastasis from renal cell carcinoma. J Neurosurg Spine (2013) 0.86
Extended lateral parascapular approach for resection of a giant multi-compartment thoracic schwannoma. Acta Neurochir (Wien) (2008) 0.85
A randomized controlled study comparing rofecoxib, diclofenac sodium, and placebo in post-bunionectomy pain. Curr Med Res Opin (2004) 0.85
Delta-aminolevulinic acid dehydratase polymorphism and risk of brain tumors in adults. Environ Health Perspect (2005) 0.85
Compensation of geometric distortion effects on intraoperative magnetic resonance imaging for enhanced visualization in image-guided neurosurgery. Neurosurgery (2008) 0.85
Sarcomatous change after sellar irradiation in a growth hormone-secreting pituitary adenoma. Can J Neurol Sci (2003) 0.85